Journal Home
Search for

Volume 92, Issue 4, Pages 1284-1289 (October 2009)


View previous. 24 of 89 View next.

Relationship of progesterone/estradiol ratio on day of hCG administration and pregnancy outcomes in high responders undergoing in vitro fertilization

Fa-Kung Lee, M.D., M.P.H.ab, Tsung-Hsuan Lai, M.D.cd, Tseng-Kai Lin, M.D.ab, Shang-Gwo Horng, M.D., M.P.H.aCorresponding Author Informationemail address, Su-Chee Chen, M.D.cd

Received 3 February 2008; received in revised form 9 July 2008; accepted 7 August 2008. published online 01 October 2008.

Objective

To evaluate the predictive value of a serum P/E2 ratio measured on the day of hCG administration regarding pregnancy outcomes in high responders undergoing IVF.

Design

Retrospective study.

Setting

Teaching hospital.

Patient(s)

Two hundred twenty-three infertile women classified as high responders in IVF-ET cycles.

Intervention(s)

Eligible infertile women undergoing IVF were assigned to four groups according to serum P levels on the day of hCG administration: group 1, P≤0.9 ng/mL; group 2, 0.9 < P≤1.4 ng/mL; group 3, 1.4 < P≤2.0 ng/mL; group 4, P>2.0 ng/mL. The relationship of E2 level and P/E2 ratio on the day of hCG administration and pregnancy outcomes was analyzed.

Main Outcome Measure(s)

Implantation and pregnancy rate.

Result(s)

Patients in group 4 had highest E2 level and P/E2 ratio, as well as lowest implantation and pregnancy rates. Using P for grouping, the sensitivity/positive predictive values (%/%) of P/E2 ratio in the four groups were 15/66, 30/65, 30/60, and 25/41, respectively.

Conclusion(s)

Using the level of a single sex hormone on hCG day to predict pregnancy outcome in high responders undergoing IVF is confounding, whereas using a P/E2 ratio on hCG day is theoretically reasonable. However, the low sensitivity and positive predictive value make the use of P/E2 clinically unfeasible.

a Department of Obstetrics and Gynecology, Cathay General Hospital, HsinChu Branch, HsinChu, Taiwan

b Department of Medical Laboratory Science and Biotechnology, Yuanpei University, Hsin Chu, Taiwan

c Fu Jen Catholic University School of Medicine, Taipei, Taiwan

d Department of Obstetrics and Gynecology, Cathay General Hospital, Taipei, Taiwan

Corresponding Author InformationReprint requests: Dr. Shang-Gwo Horng, M.D., Department of Obstetrics and Gynecology, Cathay General Hospital, HsinChu Branch, HsinChu, Taiwan, No 678, Section 2, Junghua Rd., HsinChu City, Taiwan (FAX: 886-3-5263199).

 F.-K.L. has nothing to disclose. T.-H.L. has nothing to disclose. T.-K.L. has nothing to disclose. S.-G.H. has nothing to disclose. S.-C.C. has nothing to disclose.

PII: S0015-0282(08)03354-2

doi:10.1016/j.fertnstert.2008.08.024


View previous. 24 of 89 View next.